Jazayeri, B., Guske, C., Harrs, C., Fazili, A. N., Wen, L., Xu, H., Zemp, L., Yu, A., Gilbert, S. M., Poch, M. A., Spiess, P. E., Sexton, W. J., Linscott, J., Li, R. (2025). Outcomes of additional BCG versus sequential gemcitabine + docetaxel in BCG-exposed high-risk non–muscle-invasive bladder cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e16600